High Growth Tech Stocks To Consider This January 2025

As global markets navigate the complexities of easing inflation and robust bank earnings, major U.S. stock indexes have rebounded, with value stocks outperforming growth shares amid a backdrop of strong economic indicators. In this dynamic environment, identifying high-growth tech stocks involves looking for companies that exhibit resilience and innovation in sectors poised to benefit from current market trends and economic shifts.

Advertisement

Top 10 High Growth Tech Companies

NameRevenue GrowthEarnings GrowthGrowth RatingShanghai Baosight SoftwareLtd21.82%25.22%★★★★★★Seojin SystemLtd35.41%39.86%★★★★★★Clinuvel Pharmaceuticals21.39%26.17%★★★★★★eWeLLLtd26.41%28.82%★★★★★★Yggdrazil Group30.20%87.10%★★★★★★Medley20.97%27.22%★★★★★★Mental Health TechnologiesLtd25.83%113.12%★★★★★★Fine M-TecLTD36.52%135.02%★★★★★★Dmall29.53%88.37%★★★★★★Delton Technology (Guangzhou)20.25%29.52%★★★★★★

Click here to see the full list of 1227 stocks from our High Growth Tech and AI Stocks screener.

Here's a peek at a few of the choices from the screener.

PharmaResearch (KOSDAQ:A214450)

Simply Wall St Growth Rating: ★★★★★☆

Overview: PharmaResearch Co., Ltd. is a South Korean biopharmaceutical company that operates with its subsidiaries in the industry, with a market cap of approximately ₩2.50 trillion.

Operations: PharmaResearch, along with its subsidiaries, focuses on the biopharmaceutical sector in South Korea, generating revenue primarily from its Pharmaceuticals segment, which amounts to approximately ₩317 billion.

PharmaResearch, a standout in the biotech sector, has demonstrated robust financial and operational performance. With earnings growth of 36.8% last year outpacing the industry average of 7.9%, the company is on a trajectory that exceeds many peers. Its revenue growth forecast at 22.2% annually is set to outperform the broader KR market's 9.4%. Furthermore, PharmaResearch's commitment to innovation is evident from its R&D investments, crucial for maintaining its competitive edge in developing cutting-edge pharmaceutical solutions. The firm's strategic focus on high-quality earnings and positive free cash flow underscores its operational efficiency and potential for sustained growth in a dynamic industry landscape.

KOSDAQ:A214450 Earnings and Revenue Growth as at Jan 2025
KOSDAQ:A214450 Earnings and Revenue Growth as at Jan 2025

DREAMTECH (KOSE:A192650)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: DREAMTECH Co., Ltd. specializes in the design, development, and manufacture of modules both in South Korea and internationally, with a market capitalization of approximately ₩489.19 billion.

Operations: DREAMTECH Co., Ltd. generates revenue primarily from IT & Mobile Communications and Compact Camera Modules, contributing ₩455.56 billion and ₩441.55 billion respectively. The Biometrics, Healthcare & Convergence segment adds ₩230.61 billion to the total revenue stream.

DREAMTECH has showcased a compelling growth trajectory with its earnings forecast to surge by 36.5% annually, significantly outpacing the broader KR market's projection of 28.8%. This performance is underpinned by a robust annual revenue increase of 14.7%, which also exceeds the market average growth rate of 9.4%. The company's commitment to innovation and technological advancement is evident in its strategic R&D investments, crucial for maintaining competitive edge in the fast-evolving tech landscape. Moreover, DREAMTECH recently extended its buyback plan, reinforcing confidence in its financial health and future prospects.

KOSE:A192650 Earnings and Revenue Growth as at Jan 2025
KOSE:A192650 Earnings and Revenue Growth as at Jan 2025

SAP (XTRA:SAP)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: SAP SE, along with its subsidiaries, offers a range of applications, technology, and services globally with a market capitalization of €305.27 billion.

Operations: The company's primary revenue stream is from its Applications, Technology & Services segment, generating €33.27 billion. The focus on this segment highlights its significance in SAP's overall business model.

SAP's strategic collaborations and product innovations underscore its adaptability in the evolving tech landscape. With a robust annual revenue growth of 10.6% and an impressive earnings forecast of 41.4% per year, SAP is outpacing the German market significantly. The recent launch of RISE with SAP on IBM Power Virtual Server highlights its commitment to facilitating faster cloud migrations, which is critical as businesses increasingly seek efficient, scalable ERP solutions. This initiative not only enhances SAP's service offering but also solidifies its position by leveraging high-security and reliable server environments to reduce migration times significantly—underpinning potential future growth in cloud-based ERP solutions.

XTRA:SAP Revenue and Expenses Breakdown as at Jan 2025
XTRA:SAP Revenue and Expenses Breakdown as at Jan 2025

Make It Happen

Ready To Venture Into Other Investment Styles?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About KOSE:A192650

DREAMTECH

Engages in the design, development, and manufacture of modules in South Korea and internationally.

Flawless balance sheet and undervalued.

Advertisement

Weekly Picks

TA
Talos
TSLA logo
Talos on Tesla ·

The "Physical AI" Monopoly – A New Industrial Revolution

Fair Value:US$665.3635.6% undervalued
24 users have followed this narrative
14 users have commented on this narrative
16 users have liked this narrative
MA
CSG logo
Marek_Trnka on CSG ·

Czechoslovak Group - is it really so hot?

Fair Value:€5547.3% undervalued
33 users have followed this narrative
1 users have commented on this narrative
13 users have liked this narrative
AL
alex30free
SECARE logo
alex30free on Swedencare ·

The Compound Effect: From Acquisition to Integration

Fair Value:SEK 46.2850.2% undervalued
8 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

MI
Minesweeper
6125 logo
Minesweeper on Okamoto Machine Tool Works ·

Okamoto Machine Tool Works focus on profitability

Fair Value:JP¥6.91k35.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AL
alex30free
STORY B logo
alex30free on Storytel ·

Storytel’s Second Act: From Market Land Grab to High Margin Ecosystem

Fair Value:SEK 119.3128.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
AnimalDoctorKwon
NOTV logo
AnimalDoctorKwon on Inotiv ·

Inotiv NAMs Test Center

Fair Value:US$1.273.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OO
NEO logo
OOO97 on Neo Performance Materials ·

Undervalued Key Player in Magnets/Rare Earth

Fair Value:CA$25.3317.2% undervalued
78 users have followed this narrative
0 users have commented on this narrative
20 users have liked this narrative
DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.887.7% undervalued
57 users have followed this narrative
5 users have commented on this narrative
25 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$603.2233.0% undervalued
1264 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative

Trending Discussion

Advertisement